Real Relief for Teens When Traditional Treatments Aren’t Enough

WHY THIS MATTERS

Depression in adolescents is common — nearly 1 in 5 US teenagers experience a major depressive episode each year. Traditional medications and therapy often help, but not always. NeuroStar TMS provides a non-drug, non-invasive option that goes directly to the brain’s mood-regulating circuits.

In March 2024, the FDA cleared NeuroStar TMS for adolescents aged 15 to 21 as an adjunct treatment for major depressive disorder (MDD). It is the first and only FDA-cleared transcranial magnetic stimulation therapy for this age group.

​

WHO MAY BENEFIT

NeuroStar TMS may be considered for teens who:

• Are 15 years or older

• Have been diagnosed with Major Depressive Disorder (MDD)

• Have not responded adequately to antidepressants or therapy

• Are seeking alternatives that do not add systemic medications

​

​

REAL-WORLD IMPROVEMENT

In real-world data collected from adolescents treated with NeuroStar TMS, a majority experienced meaningful reductions in depression symptoms, with many showing clinical improvement or remission.​​

​

​

WHAT TO EXPECT

1. Clinical evaluation with a psychiatrist

2. Review of prior treatments and medical history

3. NeuroStar treatment sessions scheduled (typically daily for several weeks)

4. Ongoing monitoring of mood and safety

5. Treatment is always individualized with parental involvement and clinician oversight.